Project Profile:A Chinese pharmaceutical production company plans to sell drugs through United States market channels, and the initial demand for the project focuses on the “NDC number”. The old station’s public case has been hidden from clients, brands, pharmaceutical names, Labeler Code, NDC, production address and contact information; This page continues anonymous processing.
Main judgements in the project
- The possible listing routes are combed according to the type of drug, active ingredient, agent type, applicable population and mode of distribution.
- Check whether NDA/ANDA, OTC Monochorph or other conditions of approval are involved to avoid mistaking listing tasks as market access approvals.
- Identification of the sequencing of drug facility registration, Labeler Code, NDC structure, Drug Listing and label information.
- Distinguishing Labeler from the actual production plant, which assumes brand/label responsibility, and avoiding the simple use of Labeler Code as factory code.
Service process
- Path communication:Collect basic information on drug types, compositions, agent types, market uses etc., and identify listing routes to be further verified.
- Business register:Assisting in the collation of the legal name of the enterprise, the address of the facility, the contact person and information on its activities.
- Labeler Code and NDC Planning:Combination of code structures by product and packaging information and information on responsible subjects.
- Drug Listing is ready:Collapse product names, active ingredients, formulations, routes of delivery, packaging and labelling information, and describe follow-up maintenance.
Scope of services completed
Services documented in the past site public case include FDA regulatory path analysis, Drug Economic Regulation Documentation, Labeler Code application, NDC structural planning, Drug Listing information preparation, submission process support and follow-up maintenance guidance. The old text does not disclose the numbering, processing time or FDA product approval results, and no extrapolation is included on this page.
Reference to similar enterprises
Do not start directly with "Application of NDC". The applicable listing path and the subject of responsibility for the product are identified, followed by item-by-item verification of the facility’s registration, Labler Code, Drug Listing, labels, applications for approval and maintenance of information. The NCDC Directory entry does not itself prove that a drug has been approved by the FDA.
Official reference
- FDA:How to Register a Drug Establishment
- FDA:How to Request a Labeler Code
- FDA:Drug Registration and Listing Instructions
- FDA:National Drug Code Directory
Source: ALL REG WordPress published case articles (2025-08-25). Content reconciliation date: 2026-10-27. Customer identification and identifiable project information remains anonymous in their original language.
Communication of similar medicines projectsView pricing and order online ↗